Literature DB >> 28339582

Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells.

Nicole Colwell1, Mioara Larion1, Amber J Giles1, Ashlee N Seldomridge1, Saman Sizdahkhani1, Mark R Gilbert1, Deric M Park1.   

Abstract

Glioblastoma is the most common and aggressive malignant primary brain tumor. Cellular heterogeneity is a characteristic feature of the disease and contributes to the difficulty in formulating effective therapies. Glioma stem-like cells (GSCs) have been identified as a subpopulation of tumor cells that are thought to be largely responsible for resistance to treatment. Intratumoral hypoxia contributes to maintenance of the GSCs by supporting the critical stem cell traits of multipotency, self-renewal, and tumorigenicity. This review highlights the interaction of GSCs with the hypoxic tumor microenvironment, exploring the mechanisms underlying the contribution of GSCs to tumor vessel dynamics, immune modulation, and metabolic alteration. Published by Oxford University Press on behalf of the Society for Neuro-Oncology 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  cancer stem cell; glioblastoma; hypoxia; tumor metabolism

Mesh:

Year:  2017        PMID: 28339582      PMCID: PMC5570138          DOI: 10.1093/neuonc/now258

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  95 in total

1.  Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors.

Authors:  Angelica Facoetti; Rosanna Nano; Paola Zelini; Patrizia Morbini; Eugenio Benericetti; Mauro Ceroni; Michael Campoli; Soldano Ferrone
Journal:  Clin Cancer Res       Date:  2005-12-01       Impact factor: 12.531

Review 2.  The functional interplay between systemic cancer and the hematopoietic stem cell niche.

Authors:  Amber J Giles; Christopher D Chien; Caitlin M Reid; Terry J Fry; Deric M Park; Rosandra N Kaplan; Mark R Gilbert
Journal:  Pharmacol Ther       Date:  2016-09-02       Impact factor: 12.310

3.  Evidence for an alternative glycolytic pathway in rapidly proliferating cells.

Authors:  Matthew G Vander Heiden; Jason W Locasale; Kenneth D Swanson; Hadar Sharfi; Greg J Heffron; Daniel Amador-Noguez; Heather R Christofk; Gerhard Wagner; Joshua D Rabinowitz; John M Asara; Lewis C Cantley
Journal:  Science       Date:  2010-09-17       Impact factor: 47.728

Review 4.  Interdependence of hypoxic and innate immune responses.

Authors:  Victor Nizet; Randall S Johnson
Journal:  Nat Rev Immunol       Date:  2009-09       Impact factor: 53.106

5.  VEGF Trap induces antiglioma effect at different stages of disease.

Authors:  Candelaria Gomez-Manzano; Jocelyn Holash; Juan Fueyo; Jing Xu; Charles A Conrad; Kenneth D Aldape; John F de Groot; B Nebiyou Bekele; W K Alfred Yung
Journal:  Neuro Oncol       Date:  2008-08-14       Impact factor: 12.300

6.  Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion.

Authors:  Balint Otvos; Daniel J Silver; Erin E Mulkearns-Hubert; Alvaro G Alvarado; Soumya M Turaga; Mia D Sorensen; Patricia Rayman; William A Flavahan; James S Hale; Kevin Stoltz; Maksim Sinyuk; Qiulian Wu; Awad Jarrar; Sung-Hak Kim; Paul L Fox; Ichiro Nakano; Jeremy N Rich; Richard M Ransohoff; James Finke; Bjarne W Kristensen; Michael A Vogelbaum; Justin D Lathia
Journal:  Stem Cells       Date:  2016-05-27       Impact factor: 6.277

7.  Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival.

Authors:  Ashwatha Narayana; Patrick Kelly; John Golfinos; Erik Parker; Glyn Johnson; Edmond Knopp; David Zagzag; Ingeborg Fischer; Shahzad Raza; Praveen Medabalmi; Patricia Eagan; Michael L Gruber
Journal:  J Neurosurg       Date:  2009-01       Impact factor: 5.115

8.  Purification and characterization of mouse hematopoietic stem cells.

Authors:  G J Spangrude; S Heimfeld; I L Weissman
Journal:  Science       Date:  1988-07-01       Impact factor: 47.728

9.  In vivo T cell activation in lymphoid tissues is inhibited in the oxygen-poor microenvironment.

Authors:  Akio Ohta; Rohan Diwanji; Radhika Kini; Meenakshi Subramanian; Akiko Ohta; Michail Sitkovsky
Journal:  Front Immunol       Date:  2011-07-05       Impact factor: 7.561

10.  Lactate dehydrogenase-A inhibition induces human glioblastoma multiforme stem cell differentiation and death.

Authors:  Simona Daniele; Chiara Giacomelli; Elisa Zappelli; Carlotta Granchi; Maria Letizia Trincavelli; Filippo Minutolo; Claudia Martini
Journal:  Sci Rep       Date:  2015-10-23       Impact factor: 4.379

View more
  78 in total

1.  Dissecting and rebuilding the glioblastoma microenvironment with engineered materials.

Authors:  Kayla J Wolf; Joseph Chen; Jason Coombes; Manish K Aghi; Sanjay Kumar
Journal:  Nat Rev Mater       Date:  2019-08-16       Impact factor: 66.308

Review 2.  Hypoxia in solid tumors: a key promoter of cancer stem cell (CSC) resistance.

Authors:  Masoud Najafi; Bagher Farhood; Keywan Mortezaee; Ebrahim Kharazinejad; Jamal Majidpoor; Reza Ahadi
Journal:  J Cancer Res Clin Oncol       Date:  2019-11-16       Impact factor: 4.553

3.  Expansion sequencing: Spatially precise in situ transcriptomics in intact biological systems.

Authors:  Shahar Alon; Daniel R Goodwin; Anubhav Sinha; Asmamaw T Wassie; Fei Chen; George M Church; Adam H Marblestone; Edward S Boyden; Evan R Daugharthy; Yosuke Bando; Atsushi Kajita; Andrew G Xue; Karl Marrett; Robert Prior; Yi Cui; Andrew C Payne; Chun-Chen Yao; Ho-Jun Suk; Ru Wang; Chih-Chieh Jay Yu; Paul Tillberg; Paul Reginato; Nikita Pak; Songlei Liu; Sukanya Punthambaker; Eswar P R Iyer; Richie E Kohman; Jeremy A Miller; Ed S Lein; Ana Lako; Nicole Cullen; Scott Rodig; Karla Helvie; Daniel L Abravanel; Nikhil Wagle; Bruce E Johnson; Johanna Klughammer; Michal Slyper; Julia Waldman; Judit Jané-Valbuena; Orit Rozenblatt-Rosen; Aviv Regev
Journal:  Science       Date:  2021-01-29       Impact factor: 47.728

Review 4.  The versatile role of HuR in Glioblastoma and its potential as a therapeutic target for a multi-pronged attack.

Authors:  Abhishek Guha; Saboora Waris; Louis B Nabors; Natalia Filippova; Myriam Gorospe; Thaddaeus Kwan; Peter H King
Journal:  Adv Drug Deliv Rev       Date:  2021-12-16       Impact factor: 15.470

5.  Exosomal microRNA-210 is a potentially non-invasive biomarker for the diagnosis and prognosis of glioma.

Authors:  Fengming Lan; Xiao Yue; Tingyi Xia
Journal:  Oncol Lett       Date:  2020-01-07       Impact factor: 2.967

Review 6.  Aberrant miRNAs Regulate the Biological Hallmarks of Glioblastoma.

Authors:  Wanli Yu; Sai Liang; Chunzhi Zhang
Journal:  Neuromolecular Med       Date:  2018-09-04       Impact factor: 3.843

7.  Hypoxic glioma-derived exosomes deliver microRNA-1246 to induce M2 macrophage polarization by targeting TERF2IP via the STAT3 and NF-κB pathways.

Authors:  Mingyu Qian; Shaobo Wang; Xiaofan Guo; Jian Wang; Zongpu Zhang; Wei Qiu; Xiao Gao; Zihang Chen; Jianye Xu; Rongrong Zhao; Hao Xue; Gang Li
Journal:  Oncogene       Date:  2019-09-04       Impact factor: 9.867

Review 8.  Altered Metabolism in Glioblastoma: Myeloid-Derived Suppressor Cell (MDSC) Fitness and Tumor-Infiltrating Lymphocyte (TIL) Dysfunction.

Authors:  Natalia Di Ianni; Silvia Musio; Serena Pellegatta
Journal:  Int J Mol Sci       Date:  2021-04-24       Impact factor: 5.923

9.  Feasibility of glioblastoma tissue response mapping with physiologic BOLD imaging using precise oxygen and carbon dioxide challenge.

Authors:  Vittorio Stumpo; Martina Sebök; Christiaan Hendrik Bas van Niftrik; Katharina Seystahl; Nicolin Hainc; Zsolt Kulcsar; Michael Weller; Luca Regli; Jorn Fierstra
Journal:  MAGMA       Date:  2021-12-07       Impact factor: 2.310

Review 10.  Glioblastoma Metabolomics-In Vitro Studies.

Authors:  Karol Jaroch; Paulina Modrakowska; Barbara Bojko
Journal:  Metabolites       Date:  2021-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.